<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18700" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Left Bundle Branch Block</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Scherbak</surname>
            <given-names>Dmitriy</given-names>
          </name>
          <aff>Rocky Vista University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shams</surname>
            <given-names>Pirbhat</given-names>
          </name>
          <aff>The Aga Khan University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hicks</surname>
            <given-names>Gregory J.</given-names>
          </name>
          <aff>Rocky Vista University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dmitriy Scherbak declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pirbhat Shams declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gregory Hicks declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18700.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Left bundle branch block (LBBB) is a cardiac conduction disorder that affects the left bundle branch of the heart's conduction system, leading to delayed or abnormal electrical impulses through the ventricles. This condition is commonly associated with structural heart diseases such as ischemic heart disease, cardiomyopathies, and valvular disorders. In some cases, LBBB may be discovered incidentally in healthy individuals, particularly in older adults. New-onset LBBB, especially in the context of acute coronary syndromes, is considered an ST-segment elevation equivalent, indicating a potential risk of myocardial infarction. LBBB is also linked to an increased likelihood of developing heart failure and arrhythmias, such as atrial fibrillation or ventricular tachycardia.</p>
        <p>This course provides healthcare professionals with an in-depth understanding of the evaluation and management of LBBB, emphasizing the condition's underlying causes, diagnostic challenges, and treatment options. Participants learn to work collaboratively with an interprofessional team, including cardiologists, primary care clinicians, and electrophysiologists, to ensure comprehensive patient care. By enhancing communication and coordination between team members, clinicians can optimize diagnosis, reduce complications, and improve long-term outcomes for patients with LBBB.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical features indicative of left bundle branch block.</p></list-item><list-item><p>Create a clinically guided diagnostic strategy for&#x000a0;left bundle branch block.</p></list-item><list-item><p>Implement individualized management plans for left bundle branch block cases.</p></list-item><list-item><p>Apply effective strategies to improve care coordination among interprofessional team members to facilitate positive outcomes for patients&#x000a0;with left bundle branch block.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18700&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18700">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18700.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Left bundle branch block (LBBB) is an intraventricular conduction abnormality usually caused by ischemic or mechanical factors affecting the cardiac conduction system's left bundle branch.&#x000a0;The condition can be seen in association with structural heart diseases, such as ischemic or valvular heart disease, and cardiomyopathies, including dilatation, hypertrophic, fibrotic, or infiltrative cardiomyopathies. LBBB&#x000a0;may also be caused by Lev or Len&#x000e8;gre disease. A complete LBBB results in an abnormal left ventricular activation sequence and diffuse slowing of cardiac conduction. LBBB appears as a widened QRS complex with certain characteristic features on electrocardiography, described below.&#x000a0;</p>
        <p>
<bold>Anatomy</bold>
</p>
        <p>The atrioventricular bundle is in the triangle of Koch, a space located in the base of the right atrium, which is bounded by the septal leaflet of the tricuspid valve, tendon of Todaro, and coronary sinus orifice. The His bundle is a cylindrical fascicle connecting the&#x000a0;atrioventricular node to the bundle branches. The&#x000a0;LBB emerges from a triangle at the inferior border of the membranous septum, between the right and noncoronary cusps of the aortic valve. The LBB receives its blood supply from branches of the left anterior descending and posterior descending arteries,&#x000a0;with the latter diverging from&#x000a0;the right coronary artery in 85% to 90% of people. The LBB trunk has a length of 9 mm and a diameter of 5 mm at the start and 9 mm at the end (reverse trapezoid).&#x000a0;This segment&#x000a0;then divides into&#x000a0;3 fiber groups: the left anterior, posterior, and septal fascicles.<xref ref-type="bibr" rid="article-18700.r1">[1]</xref>&#x000a0;&#x000a0;</p>
        <p>
<bold>Clinical Significance</bold>
</p>
        <p>The clinical significance of LBBB in asymptomatic individuals is controversial.&#x000a0;LBBB often appears in the setting of other cardiovascular diseases, such as hypertension, coronary artery disease, or cardiomyopathy.&#x000a0;This condition may also occur incidentally in otherwise healthy individuals, particularly those of advanced age.&#x000a0;The presence of&#x000a0;this rhythm abnormality in middle-aged and older individuals is associated with an increased risk of adverse cardiovascular events, such as heart failure, sudden cardiac death, and cardiovascular mortality.<xref ref-type="bibr" rid="article-18700.r2">[2]</xref></p>
        <p>LBBB is a predictor of worse outcomes in patients with heart failure, including recurrent hospitalization and mortality. The presence of LBBB in different cardiomyopathies confers adverse outcomes.&#x000a0;The&#x000a0;Rotterdam Study, a large population-based investigation, found that asymptomatic, older individuals with LBBB had a higher risk of developing heart failure and experiencing cardiovascular death compared to people without LBBB.</p>
        <p>LBBB can develop gradually or suddenly. New-onset LBBB in&#x000a0;the appropriate clinical context is considered an ST-segment elevation equivalent.<xref ref-type="bibr" rid="article-18700.r3">[3]</xref>&#x000a0;In some individuals, particularly those without significant underlying heart disease, LBBB may remain stable for many years without causing symptoms or complications. In cases of structural heart disease, the presence of LBBB can exacerbate dyssynchrony in ventricular contraction, further impairing cardiac function.&#x000a0;LBBB is associated with an increased risk of developing arrhythmias, such as atrial fibrillation or ventricular tachycardia.</p>
        <p>
<bold>Natural History</bold>
</p>
        <p>The natural history of LBBB varies widely depending on the presence and progression of underlying cardiovascular conditions. While some individuals with LBBB may remain asymptomatic with a stable course, others may experience worsening cardiac function, arrhythmias, and heart failure, increasing their&#x000a0;mortality risk. Regular monitoring and appropriate management, including the potential use of therapies like&#x000a0;cardiac resynchronization therapy, are key to improving outcomes in patients with LBBB.<xref ref-type="bibr" rid="article-18700.r4">[4]</xref></p>
      </sec>
      <sec id="article-18700.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>LBBB&#x000a0;arises from various factors and conditions that can affect the electrical conduction system.&#x000a0;The underlying causes can be broadly categorized into structural heart disease, degenerative changes, and other less common factors.</p>
        <list list-type="bullet">
          <list-item>
            <p>Structural heart disease: Coronary artery disease (CAD), hypertension, cardiomyopathies&#x000a0;such as dilated,&#x000a0;left ventricular noncompaction, stress, and hypertrophic cardiomyopathies, and aortic valve diseases&#x000a0;like aortic stenosis&#x000a0;and regurgitation</p>
          </list-item>
          <list-item>
            <p>Degenerative changes: Age-related fibrosis, Lev disease,&#x000a0;and Len&#x000e8;gre disease
<list list-type="bullet"><list-item><p>Lev disease&#x000a0;is a form of idiopathic, age-related progressive cardiac conduction disorder characterized by&#x000a0;extensive calcification and fibrosis of the cardiac skeleton, including the aortic valve annulus, mitral valve annulus, and interventricular septum. This calcification can extend to involve the His bundle and the bundle branches,&#x000a0;manifesting as bundle branch blocks, commonly LBBB, and varying degrees of atrioventricular block, which can progress to complete heart block.&#x000a0;Len&#x000e8;gre disease&#x000a0;involves age-related, progressive degeneration of the conduction fibers, leading to fibrosis and sclerosis. This degeneration typically affects the His bundle and its branches, leading to&#x000a0;various conduction blocks, LBBB being the most common.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Infiltrative conditions: sarcoidosis or amyloidosis</p>
          </list-item>
          <list-item>
            <p>Inflammatory cardiomyopathies: Infectious myocarditis or autoimmune disease</p>
          </list-item>
          <list-item>
            <p>Iatrogenic: Following cardiac surgery&#x000a0;involving the aortic valve or interventricular septum or&#x000a0;after transcatheter aortic valve replacement (TAVR)
<list list-type="bullet"><list-item><p>At least 30% to 50% of patients develop LBBB after TAVR, which independently predicts mortality in these patients.<xref ref-type="bibr" rid="article-18700.r5">[5]</xref>&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Electrolyte imbalance: Hyperkalemia</p>
          </list-item>
          <list-item>
            <p>Medication: Anti-arrhythmic medications</p>
          </list-item>
          <list-item>
            <p>Congenital structural heart disease</p>
          </list-item>
          <list-item>
            <p>Idiopathic: Particularly in younger patients or&#x000a0;individuals without significant cardiac risk factors&#x000a0; &#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18700.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence and prevalence of LBBB vary across different populations based on factors such as age, race, gender, and underlying cardiovascular conditions.&#x000a0;LBBB is prevalent in about 0.06% to 0.1% of the general population. In general, the incidence is reported to be about 1 to 4 cases per 1000 person-years, increasing with age.&#x000a0;In asymptomatic older individuals, particularly men, LBBB is more commonly identified incidentally during routine electrocardiography (ECG) screening.&#x000a0;In individuals&#x000a0;older than 70, the prevalence can be as high as 1%&#x000a0;to 5%. The prevalence further increases in&#x000a0;people older than 80, with some studies reporting rates as high as 6% to 7%.<xref ref-type="bibr" rid="article-18700.r6">[6]</xref></p>
        <p>The prevalence of LBBB is generally higher among White individuals compared to other ethnic groups. LBBB is more common in men than women, with prevalence approximately twice as high in some cohorts. Hispanic patients with left ventricular dysfunction have an increased incidence of LBBB.<xref ref-type="bibr" rid="article-18700.r7">[7]</xref> Approximately 33% of patients with heart failure have LBBB; the incidence increases with the severity of left ventricular failure.<xref ref-type="bibr" rid="article-18700.r8">[8]</xref>&#x000a0;LBBB is quite common in individuals with dilated cardiomyopathy, with prevalence rates ranging from 10% to 26%.</p>
        <p>The Framingham Heart Study results reported that&#x000a0;LBBB is more frequently observed in&#x000a0;people with a history of hypertension, particularly when the condition is longstanding or poorly controlled. The study&#x000a0;reports&#x000a0;a&#x000a0;significant association between LBBB and CAD. LBBB in individuals with CAD often indicates more extensive myocardial ischemia or infarction and is associated with a worse prognosis.&#x000a0;The study also reported that&#x000a0;LBBB is associated with a higher risk of developing heart failure and&#x000a0;an increased risk of all-cause mortality, cardiovascular mortality, and sudden cardiac death.<xref ref-type="bibr" rid="article-18700.r9">[9]</xref></p>
      </sec>
      <sec id="article-18700.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The septum on the left ventricular side is normally activated first through left-to-right conduction via the small septal branch of the left bundle. In LBBB, conduction shifts to the right bundle, leading to right-to-left activation. The resulting changes include the loss of lateral Q waves and the appearance of tall R waves in lateral leads. After the septum, the remaining left ventricle is activated by functional muscle fibers instead of the His-Purkinje system (HPS), with leftward and posterior conduction, causing broad, notched, or slurred R waves in lateral leads.</p>
        <p>
<bold>Electrical Dyssynchrony</bold>
</p>
        <p>In a normal HPS, the impulse travels down longitudinally with a fast conduction velocity of 1.5 m/s. This speed is facilitated by the high saturation of gap junctions and the longitudinal arrangement of cells. A LBBB results from direct damage to the LBB as a result of conduction delay within the HPS and into the myocardium or a combination of both. With LBBB, the right ventricle is activated first, followed by a right-to-left septal transmission and activation of the left ventricular endocardium at the level of the midseptum.&#x000a0;</p>
        <p>
<bold>Mechanical Dyssynchrony</bold>
</p>
        <p>In LBBB, the&#x000a0;septum is activated before aortic valve opening (isovolumetric contraction), stretching the posterior and lateral walls. The posterior and lateral walls are activated later, which stretches the septum. Consequently, dyssynchronous contraction of the&#x000a0;left ventricle&#x000a0;occurs,&#x000a0;causing a mechanical disadvantage.&#x000a0;</p>
        <p>
<bold>Genetic Factors</bold>
</p>
        <p>Recent evidence suggests that several genes are implicated in the pathogenesis of LBBB.&#x000a0;Affected genes include&#x000a0;<italic toggle="yes">HCN4, SCN5A, LMNA, GATA4, </italic>and<italic toggle="yes"> ANK2</italic>.<xref ref-type="bibr" rid="article-18700.r10">[10]</xref></p>
      </sec>
      <sec id="article-18700.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>LBBB may be silent, especially in its early stages, or&#x000a0;present&#x000a0;with nonspecific symptoms, such as fatigue, dyspnea, and palpitations. Symptoms often arise from the underlying heart condition.<xref ref-type="bibr" rid="article-18700.r11">[11]</xref>&#x000a0;Symptoms due to underlying heart disease can include chest pain, dyspnea, fatigue, palpitations, syncope, or presyncope.&#x000a0;Signs of LBBB due to underlying heart disease can include signs of heart failure and cardiomyopathies, valvular heart disease, and systemic diseases with cardiac involvement.</p>
      </sec>
      <sec id="article-18700.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold> Electrocardiography</bold>
</p>
        <p>According to the American College of Cardiology, American Heart Association, and Heart Rhythm Society, complete LBBB is defined by the following ECG features (see <bold>Image</bold>. Left Bundle Branch Block on Electrocardiography):</p>
        <list list-type="bullet">
          <list-item>
            <p>QRS duration greater than or equal to 120 ms</p>
          </list-item>
          <list-item>
            <p>Broad notched or slurred R wave in leads I, aVL, V5, and V6 or, occasionally, an RS pattern in leads V5&#x000a0;and V6</p>
          </list-item>
          <list-item>
            <p>Absence of Q wave in leads I, V5, and V6 (with the possible exception of aVL)</p>
          </list-item>
          <list-item>
            <p>R wave peak time greater than 60 ms in leads V5&#x000a0;and V6</p>
          </list-item>
          <list-item>
            <p>ST-T wave changes opposite to the QRS direction&#x000a0;<xref ref-type="bibr" rid="article-18700.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>Strauss et al proposed these more stringent criteria:</p>
        <list list-type="bullet">
          <list-item>
            <p>QRS duration greater than or equal to 140 ms in men and greater than or equal to 130 ms&#x000a0;in women</p>
          </list-item>
          <list-item>
            <p>Broad notched or slurred R waves in left-sided leads</p>
          </list-item>
          <list-item>
            <p>Broad notched&#x000a0;or slurred QRS in right-sided leads, with QS or rS in V1&#x000a0;and V2&#x000a0;<xref ref-type="bibr" rid="article-18700.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>The European Society of Cardiology provided the following criteria for diagnosis of LBBB in 2021:</p>
        <list list-type="bullet">
          <list-item>
            <p>QRS duration greater than or equal to 120 ms</p>
          </list-item>
          <list-item>
            <p>Notches or slurring in the middle third of the QRS complex in at least 2 of the following leads: V1, V2, V5, V6, I, and aVL, with an R-wave peak time of 60 ms in lead V5 or V6</p>
          </list-item>
          <list-item>
            <p>The ST segment is slightly opposite to the QRS complex polarity</p>
          </list-item>
          <list-item>
            <p>In the horizontal plane, QS or rS in V1 with a small "r" slight ST elevation and a positive asymmetrical T wave, and a unique R wave in V6 with a negative asymmetrical T wave. When the QRS duration is less than 140 ms, the T wave in V6 may be positive</p>
          </list-item>
          <list-item>
            <p>In the frontal plane, an exclusive R wave in I&#x000a0;and aVL, often&#x000a0;with a negative asymmetrical T wave, slight ST depression, and usually a QS complex in aVR with a positive T wave</p>
          </list-item>
          <list-item>
            <p>Variable QRS axis&#x000a0;<xref ref-type="bibr" rid="article-18700.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Echocardiography</bold>
</p>
        <p>According to the 2018 guidelines&#x000a0;on the evaluation and management of bradycardia and conduction delay from the American Heart Association, American College of Cardiology Foundation, and Heart Rhythm Society, patients with newly diagnosed LBBB should undergo transthoracic echocardiogram (TTE)&#x000a0;to rule out structural heart disease.<xref ref-type="bibr" rid="article-18700.r12">[12]</xref>&#x000a0;TTE helps evaluate global and regional left ventricular systolic function. TTE, particularly with strain imaging techniques like speckle-tracking echocardiography, can assess the degree of mechanical dyssynchrony in patients with LBBB. This information is valuable for determining the suitability of CRT in patients with symptomatic heart failure&#x000a0;and LBBB.&#x000a0;</p>
        <p>M-mode echocardiography can show characteristic findings related to interventricular septal motion and the overall left ventricular contraction pattern due to electrical dyssynchrony. The M-mode&#x000a0;findings may include "septal flash" or "septal beaking," where the septum moves abruptly toward the left ventricle at the onset of systole and then quickly moves back toward the right ventricle. Dyssynchronous movement between the septum and the posterior wall is seen.</p>
        <p>Strain imaging is useful for the evaluation of LBBB. Global longitudinal strain may be reduced overall due to dyssynchronous contraction in patients with LBBB, even in the absence of myocardial infarction or overt heart failure.&#x000a0;The basal septal strain is often significantly reduced or abnormal due to the early electrical activation and paradoxical motion of the septum. In contrast, the lateral wall strain may be delayed but preserved, reflecting the dyssynchronous contraction pattern.</p>
        <p>The difference in the timing of peak strain across various myocardial segments, known as strain dispersion, is often increased in LBBB. A greater strain dispersion indicates more severe dyssynchrony, which can be predictive of the response to CRT.&#x000a0;By identifying the most dyssynchronous segments, strain imaging can guide the optimal placement of the CRT lead, usually in the most delayed region, to achieve maximal resynchronization and improve clinical outcomes.&#x000a0;Abnormal strain patterns and high strain dispersion are associated with worse outcomes in patients with LBBB and heart failure. Strain imaging can thus be used for risk stratification and guiding the timing of CRT or other interventions.&#x000a0;</p>
        <p>Pulsed-wave Doppler tissue imaging is a valuable tool for assessing mechanical dyssynchrony in LBBB. Peak systolic velocities of the left ventricle's septal and lateral walls at the basal segments are measured.&#x000a0;A time difference between peak systolic velocities of the septal and lateral walls (the "septal-to-lateral delay") greater than 60 ms&#x000a0;is often considered indicative of significant dyssynchrony.</p>
        <p>
<bold>Stress Imaging</bold>
</p>
        <p>LBBB often complicates the interpretation of noninvasive cardiac tests due to abnormal septal motion and potential perfusion defects, making stress imaging particularly valuable for differentiating between true ischemia and artifacts.</p>
        <p>During stress echocardiography, the abnormal septal motion can mimic ischemia, leading to false-positive results for CAD. The emphasis should be on&#x000a0;the assessment of wall motion abnormalities in nonseptal regions (eg, lateral or posterior walls) to avoid the confounding effects of LBBB on septal motion.&#x000a0;Dobutamine stress echocardiography is often preferred over exercise because it can provide clearer differentiation between septal pseudodyskinesis and true ischemia due to graded increment.&#x000a0;</p>
        <p>In a myocardial perfusion scan, true ischemic defects tend to be in the territories supplied by the coronary arteries (eg, anterior and lateral walls) rather than just the septum.&#x000a0;Scan results should be interpreted in conjunction with clinical findings and other imaging modalities.</p>
        <p>
<bold>Electrophysiological Study</bold>
</p>
        <p>In patients with LBBB, an electrophysiological study (EPS) can provide information about the conduction system, specifically the HPS.&#x000a0;This modality&#x000a0;can help assess the risk of progression to a more advanced&#x000a0;atrioventricular&#x000a0;or complete heart block.&#x000a0;EPS helps identify patients at high risk for sudden cardiac death who may benefit from implantable cardioverter-defibrillator (ICD) placement, especially in&#x000a0;patients with unexplained syncope and evidence of conduction disease.</p>
        <p>The inducibility of sustained monomorphic&#x000a0;ventricular tachycardia in patients with LBBB, especially those with structural heart disease, is an important finding that may warrant ICD placement.&#x000a0;A His-to-ventricular interval of greater than 70 ms is indicative of significant conduction disease in the HPS. A markedly prolonged&#x000a0;His-to-ventricular&#x000a0;interval (&#x0003e;100 ms) suggests a high risk of progression to a complete heart block. EPS can help differentiate between syncope due to bradyarrhythmia (eg,&#x000a0;atrioventricular block) and tachyarrhythmias (eg, ventricular tachycardia), which is crucial for determining the appropriate therapeutic strategy.</p>
      </sec>
      <sec id="article-18700.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of LBBB depends on the underlying structural heart disease or symptoms. Approaches are&#x000a0;based&#x000a0;on the impact of LBBB on cardiac function and its&#x000a0;relation with specific heart diseases or clinical scenarios.</p>
        <p>
<bold>Asymptomatic Individuals</bold>
</p>
        <p>A TTE is warranted for further evaluation of underlying structural heart disease in these individuals. Cardiac stress tests or anatomical&#x000a0;imaging modalities&#x000a0;like computed tomography coronary angiography (CTCA) may be indicated in&#x000a0;people with CAD risk factors.&#x000a0;</p>
        <p>
<bold>Left Bundle Branch Block in Heart Failure</bold>
</p>
        <p>A thorough medical history should be&#x000a0;obtained to determine&#x000a0;a patient's New York Heart Association (NYHA) functional class, which helps assess the severity of heart failure symptoms and guides appropriate management strategies. Any history of heart failure exacerbations or hospitalization should be documented. The ECG tracing should be evaluated thoroughly to confirm the presence of LBBB based on known criteria. A&#x000a0;TTE should be performed to assess the left ventricular ejection fraction (LVEF).</p>
        <p>Standard medical therapy for&#x000a0;heart failure should be initiated and&#x000a0;optimized as tolerated.&#x000a0;Pharmacologic options include angiotensin-converting enzyme inhibitors (or angiotensin receptor blockers), &#x003b2;-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter-2 inhibitors.&#x000a0;Cardiac resynchronization therapy (CRT) is indicated in patients with sinus rhythm, NYHA functional class II, III, or ambulatory IV heart failure despite optimal medical therapy, an LVEF&#x000a0;of 35% or less,&#x000a0;QRS duration greater than or equal to 150 ms with&#x000a0;LBBB&#x000a0;morphology, and a meaningful expected survival longer than 1 year. CRT improves symptoms and quality of life and reduces mortality and hospitalization in these patients.<xref ref-type="bibr" rid="article-18700.r14">[14]</xref></p>
        <p>
<bold>Painful&#x000a0;<bold>Left Bundle Branch Block</bold>&#x000a0;Syndrome</bold>
</p>
        <p>This condition is also known as "exercise-induced LBBB."&#x000a0;Painful LBBB syndrome is a rare&#x000a0;disorder&#x000a0;characterized by&#x000a0;chest pain or discomfort specifically associated with the onset of LBBB, usually during physical activity or exercise. The pain typically mimics angina, but it occurs without evidence of obstructive CAD. Conducting a treadmill or pharmacologic stress test can reproduce symptoms and document the timing of LBBB onset in relation to exercise. An invasive coronary angiogram or CTCA may be performed if clinical suspicion is high. &#x003b2;-blocker&#x000a0;use must be considered to reduce myocardial oxygen demand and potentially&#x000a0;minimize the&#x000a0;occurrence of LBBB during exercise. Nondihydropyridine calcium channel blockers may be used in individuals who cannot tolerate &#x003b2;-blockers.&#x000a0;</p>
        <p>
<bold><bold>Left Bundle Branch Block</bold> in Coronary Artery Disease</bold>
</p>
        <p>LBBB can obscure ST-segment elevations or depressions, which are critical for diagnosing acute myocardial infarction (AMI). The Sgarbossa criteria can aid in diagnosis.&#x000a0;This set of criteria&#x000a0;includes&#x000a0;ST-segment elevation greater than or equal to 1 mm in leads with a positive QRS complex, concordant ST-segment elevation more than or equal to 1 mm in any lead, or ST-segment depression greater than or equal to 1 mm in leads V1 to V3.<xref ref-type="bibr" rid="article-18700.r15">[15]</xref>&#x000a0;Immediate reperfusion therapy is indicated if&#x000a0;AMI is suspected in a patient with LBBB and ischemic symptoms, especially if they are hemodynamically unstable or&#x000a0;demonstrate&#x000a0;dynamic ECG changes, positive biomarkers, or ECG changes suggestive of wall motion abnormalities. Management of chronic LBBB in the context of CAD&#x000a0;involves a combination of optimal medical therapy, careful diagnostic evaluation, consideration for device therapy, and potential revascularization.&#x000a0;</p>
        <p>
<bold><bold>Left Bundle Branch Block</bold> After Transcatheter Aortic Valve Replacement and Surgical Myomectomy</bold>
</p>
        <p>The presence of LBBB post-TAVR can increase the risk of developing high-grade&#x000a0;atrioventricular block, requiring permanent pacemaker implantation.&#x000a0;Surgical myomectomy for hypertrophic obstructive cardiomyopathy&#x000a0;may result in LBBB due to the disruption of the conduction system during septal muscle resection. Patients with new-onset LBBB post-TAVR or surgical myomectomy should have continuous telemetry monitoring for at least 48 to 72 hours to detect any episodes of high-grade&#x000a0;atrioventricular block or symptomatic bradycardia. Longer monitoring may be warranted in patients with other risk factors for conduction abnormalities, such as preexisting right bundle branch block or prolonged PR interval.</p>
        <p>Patients with isolated, asymptomatic LBBB without other conduction disturbances may not require immediate pacemaker implantation. These&#x000a0;individuals should have a close follow-up with repeated ECGs and possibly ambulatory monitoring (eg, Holter monitoring) to detect any delayed progression to high-grade&#x000a0;atrioventricular block.&#x000a0;High-risk patients, especially those with symptomatic conduction abnormalities or evidence of high-grade atrioventricular block, should receive a permanent pacemaker.&#x000a0;</p>
      </sec>
      <sec id="article-18700.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Incomplete <bold>Left Bundle Branch Block</bold></bold>
</p>
        <p>In incomplete LBBB, the LBB is partially impaired, causing a delay in the initial depolarization of the left ventricle. However, the impulse&#x000a0;passes through the block and normally travels to the rest of the left ventricle. Thus, on&#x000a0;ECG, the QRS complex is widened but not as wide as in complete LBBB. The QRS duration in incomplete LBBB is typically between 110 and 120 ms.&#x000a0;The characteristic broad or notched R waves seen in&#x000a0;lead I, aVL, V5, and V6 may still be present but are less marked.&#x000a0;The ECG does not show the full pattern of complete LBBB, such as the deep S waves in leads V1 and V2, which are more typical of complete LBBB. The R-wave peak time in left-sided leads measures greater than 60 ms.</p>
        <p>
<bold>Ventricular-Paced Rhythm</bold>
</p>
        <p>Ventricular-paced rhythm can produce a wide QRS complex with a morphology similar to LBBB.&#x000a0;Identification of pacemaker spikes preceding the QRS complexes or known pacemaker placement can help distinguish this clinical entity from true LBBB. A paced rhythm&#x000a0;often does not have an R wave in V6.&#x000a0;</p>
        <p>
<bold>Left Ventricular Hypertrophy</bold>
</p>
        <p>Left ventricular hypertrophy can sometimes produce a wide QRS complex with delayed intrinsicoid deflection in the lateral leads, which can resemble LBBB.&#x000a0;The Sokolow-Lyon criteria for increased QRS voltage, along with ST-segment and T-wave changes characteristic of left ventricular hypertrophy rather than typical LBBB patterns, can aid in distinguishing between the 2 conditions.</p>
        <p>
<bold>Premature Ventricular Contractions</bold>
</p>
        <p>Premature ventricular contractions (PVCs) originating from the right ventricle or septal area can produce a QRS morphology that mimics LBBB. PVCs are usually premature, and the QRS complex is wider and different from the native QRS complexes. An irregular rhythm due to ectopy helps differentiate PVCs from a consistent LBBB pattern.</p>
      </sec>
      <sec id="article-18700.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of LBBB depends on patient characteristics and underlying heart disease. LBBB generally carries a benign prognosis in asymptomatic individuals without underlying heart disease. However, studies have reported an increased risk of incident heart failure and cardiovascular mortality in asymptomatic individuals with LBBB over long-term follow-up.<xref ref-type="bibr" rid="article-18700.r16">[16]</xref>&#x000a0;</p>
        <p>In patients with underlying conditions like CAD, hypertension, or cardiomyopathy, asymptomatic LBBB is generally associated with a worse prognosis compared to those without LBBB, and LBBB can indicate an increased risk of progression to heart failure, arrhythmias, and increased mortality.&#x000a0;Patients with LBBB and&#x000a0;CAD have more adverse outcomes than patients with&#x000a0;CAD without LBBB.</p>
        <p>LBBB&#x000a0;has a 2.9 times increased risk of cardiovascular mortality and a 1.4 times increased risk for all-cause mortality. Patients with LBBB who undergo nuclear testing for suspected CAD&#x000a0;have a 50% increased risk of all-cause mortality. In patients with heart failure, the presence of&#x000a0;an LBBB is associated with increased cardiovascular outcomes and mortality.</p>
        <p>However, a recent study that attempted to isolate LBBB's sole contribution to outcomes found that, if contributions of confounders were excluded, LBBB contributed far more modestly to poor outcomes, likely because&#x000a0;this rhythm disturbance is more of a symptom of dilated cardiomyopathy as opposed to a causative agent in the progression of the disease.<xref ref-type="bibr" rid="article-18700.r17">[17]</xref>&#x000a0;Patients with LBBB are restricted from piloting aircraft in the United States and the United Kingdom, as LBBB&#x000a0;is a possible precursor to a complete atrioventricular block.<xref ref-type="bibr" rid="article-18700.r18">[18]</xref></p>
      </sec>
      <sec id="article-18700.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of LBBB include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Worsening heart failure</p>
          </list-item>
          <list-item>
            <p>Left ventricular dysfunction</p>
          </list-item>
          <list-item>
            <p>Tachyarrhythmias, such as atrial fibrillation or ventricular tachycardia</p>
          </list-item>
          <list-item>
            <p>Progression to complete heart block</p>
          </list-item>
          <list-item>
            <p>Delayed diagnosis in&#x000a0;AMI</p>
          </list-item>
        </list>
        <p>Prompt treatment and regular monitoring of affected individuals can reduce the risk of these complications.</p>
      </sec>
      <sec id="article-18700.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with LBBB should be educated on the potential seriousness of their condition, symptoms to watch for, and the importance of regular follow-up. Affected individuals should be instructed to seek medical attention&#x000a0;immediately if they develop symptoms such as chest pain, shortness of breath, palpitations, or syncope. The difference between LBBB and other types of heart blocks or arrhythmias must be discussed, emphasizing that LBBB itself is a marker that requires careful monitoring.&#x000a0;Patients should be educated about the possible need for permanent pacemaker implantation on follow-up. Individuals who may require a pacemaker or CRT must be educated about&#x000a0;the purpose of these devices, how they work, and what to expect from the procedure. Lifestyle modifications must be encouraged to manage risk factors and&#x000a0;improve quality of life.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-18700.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>In the setting of AMI, the Sgarbossa criteria&#x000a0;may be used to interpret the ECG and improve diagnostic accuracy for myocardial infarction in the presence of LBBB. These criteria are&#x000a0;less sensitive than ST-segment elevation in the absence of LBBB, as their sensitivity is only 49%, but their specificity is greater than 90%. The criteria are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Concordant ST elevation greater than 1 mm in leads with a positive QRS complex gets a score of 5 points</p>
          </list-item>
          <list-item>
            <p>Concordant ST depression greater than 1 mm in V1 to V3 gets a score of 3 points</p>
          </list-item>
          <list-item>
            <p>Discordant ST elevation greater than 5 mm in leads&#x000a0;with a negative QRS complex gets a score of 2 points</p>
          </list-item>
        </list>
        <p>Three or more points indicate AMI.</p>
        <p>The modified Sgarbossa criteria were validated in 2015. The sensitivity of the modified criteria increases to 80% without affecting specificity. The 3rd criterion, involving discordant ST elevation greater than 5 mm, was selected rather arbitrarily. The modified criteria adjust this threshold to ST elevation exceeding 25% of the negative QRS deflection.</p>
        <p>Criteria 3 is modified&#x000a0;as follows: Discordant ST elevation greater&#x000a0;than 25% of downward QRS deflection in a negative QRS complex gets a score of 2 points.</p>
        <p>
<bold>Definition of Terms</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Concordant: QRS and T waves go in the same direction.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Discordant: The QRS is in the direction opposite the T wave.</p>
          </list-item>
          <list-item>
            <p>Positive QRS Complex: The net QRS voltage goes upward from the baseline.</p>
          </list-item>
          <list-item>
            <p>Negative QRS Complex: The net QRS voltage goes downward from the baseline.<xref ref-type="bibr" rid="article-18700.r19">[19]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18700.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>LBBB may be encountered in clinical practice by the nurse practitioner, primary care provider, emergency department physician, and internist. While LBBB by itself may be a normal occurrence in some individuals, referring&#x000a0;patients&#x000a0;to a cardiologist to rule out an underlying cardiac pathology is critical.</p>
        <p>Primary care physicians are often the first to detect LBBB during routine checkups or consultations for symptoms like fatigue or palpitations. A cardiologist performs a thorough evaluation, including reviewing the patient&#x02019;s medical history, conducting physical examinations, and interpreting ECGs to confirm the presence of LBBB and assess its clinical significance.&#x000a0;These specialists order and interpret additional tests, such as echocardiography and stress testing, possibly with imaging modalities like single-photon emission computed tomography, to evaluate the impact of LBBB on cardiac function.</p>
        <p>An electrophysiologist provides a more detailed evaluation of the heart&#x02019;s electrical system, especially if concerns exist about arrhythmias or the need for&#x000a0;device implantation. Nurses or nurse practitioners provide education about LBBB, its implications, and the importance of adhering to the treatment plan. Nurses also teach patients how to monitor symptoms and understand information about their medications.</p>
      </sec>
      <sec id="article-18700.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18700&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18700">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/left-bundle-branch-block/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18700">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18700/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18700">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18700.s16">
        <fig id="article-18700.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Left Bundle Branch Block on Electrocardiography. These tracings show a left bundle branch block arising from&#x000a0;inferior wall myocardial infarction. Contributed by S Mountfort,&#x000a0;BS, CCEMTP, NCEE</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="StatPearls__ECG" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18700.s17">
        <title>References</title>
        <ref id="article-18700.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Riera</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Barbosa-Barros</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Rezende Barbosa</surname>
                <given-names>MPC</given-names>
              </name>
              <name>
                <surname>Daminello-Raimundo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Abreu</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Nikus</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Left bundle branch block: Epidemiology, etiology, anatomic features, electrovectorcardiography, and classification proposal.</article-title>
            <source>Ann Noninvasive Electrocardiol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>e12572</fpage>
            <pub-id pub-id-type="pmid">29932265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Selvester</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Defining left bundle branch block in the era of cardiac resynchronization therapy.</article-title>
            <source>Am J Cardiol</source>
            <year>2011</year>
            <month>Mar</month>
            <day>15</day>
            <volume>107</volume>
            <issue>6</issue>
            <fpage>927</fpage>
            <page-range>927-34</page-range>
            <pub-id pub-id-type="pmid">21376930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Ascheim</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>de Lemos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ettinger</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fesmire</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Linderbaum</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Newby</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Ornato</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Radford</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tamis-Holland</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tommaso</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>DX</given-names>
              </name>
            </person-group>
            <article-title>2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Jan</month>
            <day>29</day>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>e78</fpage>
            <page-range>e78-e140</page-range>
            <pub-id pub-id-type="pmid">23256914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Witt</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Left Bundle Branch Block: Current and Future Perspectives.</article-title>
            <source>Circ Arrhythm Electrophysiol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>e008239</fpage>
            <pub-id pub-id-type="pmid">32186936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hardarson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Arnason</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>El&#x000ed;asson</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>P&#x000e1;lsson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eyj&#x000f3;lfsson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sigf&#x000fa;sson</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Left bundle branch block: prevalence, incidence, follow-up and outcome.</article-title>
            <source>Eur Heart J</source>
            <year>1987</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>10</issue>
            <fpage>1075</fpage>
            <page-range>1075-9</page-range>
            <pub-id pub-id-type="pmid">3678236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmood</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vasan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.</article-title>
            <source>Lancet</source>
            <year>2014</year>
            <month>Mar</month>
            <day>15</day>
            <volume>383</volume>
            <issue>9921</issue>
            <fpage>999</fpage>
            <page-range>999-1008</page-range>
            <pub-id pub-id-type="pmid">24084292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hebert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Quevedo</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Tamariz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Steen</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Neistein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arcement</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of conduction abnormalities in a systolic heart failure population by race, ethnicity, and gender.</article-title>
            <source>Ann Noninvasive Electrocardiol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-22</page-range>
            <pub-id pub-id-type="pmid">22537329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Balla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Paneni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Volpe</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Left bundle-branch block--pathophysiology, prognosis, and clinical management.</article-title>
            <source>Clin Cardiol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>110</fpage>
            <page-range>110-5</page-range>
            <pub-id pub-id-type="pmid">17385703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Kreger</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>Newly acquired left bundle-branch block: the Framingham study.</article-title>
            <source>Ann Intern Med</source>
            <year>1979</year>
            <month>Mar</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>303</fpage>
            <page-range>303-10</page-range>
            <pub-id pub-id-type="pmid">154870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ge</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title><italic>SCN5A</italic> Variants: Association With Cardiac Disorders.</article-title>
            <source>Front Physiol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>1372</fpage>
            <pub-id pub-id-type="pmid">30364184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Goode</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cleland</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure.</article-title>
            <source>Eur J Heart Fail</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>696</fpage>
            <page-range>696-702</page-range>
            <pub-id pub-id-type="pmid">18501670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kusumoto</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Edgerton</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Goldschlager</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Oken</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Patton</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Selzman</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varosy</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.</article-title>
            <source>Circulation</source>
            <year>2019</year>
            <month>Aug</month>
            <day>20</day>
            <volume>140</volume>
            <issue>8</issue>
            <fpage>e333</fpage>
            <page-range>e333-e381</page-range>
            <pub-id pub-id-type="pmid">30586771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Timmermans</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Pooter</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Defining left bundle branch block according to the new 2021 European Society of Cardiology criteria.</article-title>
            <source>Neth Heart J</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>11</issue>
            <fpage>495</fpage>
            <page-range>495-498</page-range>
            <pub-id pub-id-type="pmid">35503400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heidenreich</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aguilar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Deswal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Dunlay</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Evers</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fedson</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Hayek</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Khazanie</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kittleson</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Milano</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Nnacheta</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Sandhu</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Vardeny</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Vest</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2022</year>
            <month>May</month>
            <day>03</day>
            <volume>145</volume>
            <issue>18</issue>
            <fpage>e895</fpage>
            <page-range>e895-e1032</page-range>
            <pub-id pub-id-type="pmid">35363499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sgarbossa</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Pinski</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Barbagelata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Gates</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Topol</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Califf</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>Feb</month>
            <day>22</day>
            <volume>334</volume>
            <issue>8</issue>
            <fpage>481</fpage>
            <page-range>481-7</page-range>
            <pub-id pub-id-type="pmid">8559200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azadani</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Soleimanirahbar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Haight</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olgin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Asymptomatic Left Bundle Branch Block Predicts New-Onset Congestive Heart Failure and Death From Cardiovascular Diseases.</article-title>
            <source>Cardiol Res</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>258</fpage>
            <page-range>258-263</page-range>
            <pub-id pub-id-type="pmid">28352414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Geraci</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Horwich</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Januzzi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wilkoff</surname>
                <given-names>BL</given-names>
              </name>
              <collab>American College of Cardiology Foundation</collab>
              <collab>American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Oct</month>
            <day>15</day>
            <volume>62</volume>
            <issue>16</issue>
            <fpage>e147</fpage>
            <page-range>e147-239</page-range>
            <pub-id pub-id-type="pmid">23747642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dambrink</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Dambrink</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Left bundle branch block and private pilot licensing.</article-title>
            <source>Aviat Space Environ Med</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>74</volume>
            <issue>12</issue>
            <fpage>1292</fpage>
            <page-range>1292-6</page-range>
            <pub-id pub-id-type="pmid">14692475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18700.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyers</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Limkakeng</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Jaffa</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Theiling</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Rezaie</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pera</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Validation of the modified Sgarbossa criteria for acute coronary occlusion in the setting of left bundle branch block: A retrospective case-control study.</article-title>
            <source>Am Heart J</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>170</volume>
            <issue>6</issue>
            <fpage>1255</fpage>
            <page-range>1255-64</page-range>
            <pub-id pub-id-type="pmid">26678648</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
